Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Vertex Pharmaceuticals: Valuation Gets Steep Despite CF Dominance [Seeking Alpha]

Vertex Pharmaceuticals Incorporated (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
Company Research Source: Seeking Alpha
Vertex Pharmaceuticals: Valuation Gets Steep Despite CF DominanceSummaryVertex Pharmaceuticals has seen a major run in 2018, driven by wider approvals of its CF franchise.The company continues to see accelerating top-line results, driven by additional FDA approvals and market share gains.With a $40 billion valuation, expectations have risen quite a bit to the extent that investors either expect domination of the CF market soon, or expansion outside this market. Show less Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VRTX alerts
Opt-in for
VRTX alerts

from News Quantified
Opt-in for
VRTX alerts

from News Quantified